Michael C. Donegan - Feb 21, 2023 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Prin. Fin. and Acctg. Officer
Signature
/s/ Michael C. Donegan
Stock symbol
TXMD
Transactions as of
Feb 21, 2023
Transactions value $
$0
Form type
4
Date filed
2/23/2023, 04:11 PM
Previous filing
Jan 30, 2023
Next filing
Apr 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +50K $0.00 50K Feb 21, 2023 Common Stock 50K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in full on March 31, 2023.